APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mycoplasma Detection Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mycoplasma Detection Service Market Outlook and Growth Opportunities 2026

5 June 2026205 pages

Choose your research edition.

Industry ResearchMycoplasma Detection Service Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Mycoplasma Detection Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Mycoplasma Detection Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mycoplasma Detection Service Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Mycoplasma Detection Service Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Mycoplasma Detection Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mycoplasma Detection Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mycoplasma Detection Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mycoplasma Detection Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mycoplasma Detection Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mycoplasma Detection Service market include Charles River Laboratories International, Thermo Fisher Scientific, SGS, Bionique Testing Laboratories, WuXi AppTec, Labcorp, IDEXX BioAnalytics, WiCell and Creative Biogene, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Mycoplasma Detection Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mycoplasma Detection Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mycoplasma Detection Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Mycoplasma Detection Service market.

Mycoplasma Detection Service Segment by Company

Charles River Laboratories International

Thermo Fisher Scientific

SGS

Bionique Testing Laboratories

WuXi AppTec

Labcorp

IDEXX BioAnalytics

WiCell

Creative Biogene

Eurofins Scientific

Hylabs

JOINN Laboratories

Shimadzu Diagnostics

CellSafe

FullHope Biomedical

Syngene International

Beyotime

CTI Cert

Shenke Bio

Mycoplasma Detection Service Segment by Type

Culture-based Mycoplasma Detection

PCR/qPCR Mycoplasma Detection

Others

Mycoplasma Detection Service Segment by Application

Biopharmaceutical Companies

Contract Research/Manufacturing Organizations (CROs/CMOs)

Universities and Research Institutions

Others

Mycoplasma Detection Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mycoplasma Detection Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Mycoplasma Detection Service key companies, revenue, market share, and recent developments.

3. To split the Mycoplasma Detection Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Mycoplasma Detection Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mycoplasma Detection Service significant trends, drivers, influence factors in global and regions.

6. To analyze Mycoplasma Detection Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mycoplasma Detection Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mycoplasma Detection Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mycoplasma Detection Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mycoplasma Detection Service industry.

Chapter 3: Detailed analysis of Mycoplasma Detection Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Mycoplasma Detection Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Mycoplasma Detection Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mycoplasma Detection Service Industry Trends Table 2. Mycoplasma Detection Service Industry Drivers Table 3. Mycoplasma Detection Service Industry Opportunities and Challenges Table 4. Mycoplasma Detection Service Industry Restraints Table 5. Global Mycoplasma Detection Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mycoplasma Detection Service Revenue Share by Company (2021-2026) Table 7. Global Mycoplasma Detection Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Mycoplasma Detection Service Key Company Manufacturing Base & Headquarters Table 9. Global Mycoplasma Detection Service Company, Product Type & Application Table 10. Global Mycoplasma Detection Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Mycoplasma Detection Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Culture-based Mycoplasma Detection Table 15. Significant Companies of PCR/qPCR Mycoplasma Detection Table 16. Significant Companies of Others Table 17. Global Mycoplasma Detection Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Mycoplasma Detection Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Mycoplasma Detection Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Mycoplasma Detection Service Sales Value Share by Type (2021-2026) Table 21. Global Mycoplasma Detection Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Biopharmaceutical Companies Table 23. Significant Companies of Contract Research/Manufacturing Organizations (CROs/CMOs) Table 24. Significant Companies of Universities and Research Institutions Table 25. Significant Companies of Others Table 26. Global Mycoplasma Detection Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Mycoplasma Detection Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Mycoplasma Detection Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Mycoplasma Detection Service Sales Value Share by Application (2021-2026) Table 30. Global Mycoplasma Detection Service Sales Value Share by Application (2027-2032) Table 31. Global Mycoplasma Detection Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Mycoplasma Detection Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Mycoplasma Detection Service Sales Value Share by Region (2021-2026) Table 34. Global Mycoplasma Detection Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Mycoplasma Detection Service Sales Value Share by Region (2027-2032) Table 36. Global Mycoplasma Detection Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Mycoplasma Detection Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Mycoplasma Detection Service Sales Value Market Share by Country (2021-2026) Table 39. Global Mycoplasma Detection Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Mycoplasma Detection Service Sales Value Market Share by Country (2027-2032) Table 41. Charles River Laboratories International Company Information Table 42. Charles River Laboratories International Business Overview Table 43. Charles River Laboratories International Mycoplasma Detection Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Charles River Laboratories International Mycoplasma Detection Service Product Portfolio Table 45. Charles River Laboratories International Recent Development Table 46. Thermo Fisher Scientific Company Information Table 47. Thermo Fisher Scientific Business Overview Table 48. Thermo Fisher Scientific Mycoplasma Detection Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Thermo Fisher Scientific Mycoplasma Detection Service Product Portfolio Table 50. Thermo Fisher Scientific Recent Development Table 51. SGS Company Information Table 52. SGS Business Overview Table 53. SGS Mycoplasma Detection Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. SGS Mycoplasma Detection Service Product Portfolio Table 55. SGS Recent Development Table 56. Bionique Testing Laboratories Company Information Table 57. Bionique Testing Laboratories Business Overview Table 58. Bionique Testing Laboratories Mycoplasma Detection Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Bionique Testing Laboratories Mycoplasma Detection Service Product Portfolio Table 60. Bionique Testing Laboratories Recent Development Table 61. WuXi AppTec Company Information Table 62. WuXi AppTec Business Overview Table 63. WuXi AppTec Mycoplasma Detection Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. WuXi AppTec Mycoplasma Detection Service Product Portfolio Table 65. WuXi AppTec Recent Development Table 66. Labcorp Company Information Table 67. Labcorp Business Overview Table 68. Labcorp Mycoplasma Detection Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Labcorp Mycoplasma Detection Service Product Portfolio Table 70. Labcorp Recent Development Table 71. IDEXX BioAnalytics Company Information Table 72. IDEXX BioAnalytics Business Overview Table 73. IDEXX BioAnalytics Mycoplasma Detection Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. IDEXX BioAnalytics Mycoplasma Detection Service Product Portfolio Table 75. IDEXX BioAnalytics Recent Development Table 76. WiCell Company Information Table 77. WiCell Business Overview Table 78. WiCell Mycoplasma Detection Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. WiCell Mycoplasma Detection Service Product Portfolio Table 80. WiCell Recent Development Table 81. Creative Biogene Company Information Table 82. Creative Biogene Business Overview Table 83. Creative Biogene Mycoplasma Detection Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Creative Biogene Mycoplasma Detection Service Product Portfolio Table 85. Creative Biogene Recent Development Table 86. Eurofins Scientific Company Information Table 87. Eurofins Scientific Business Overview Table 88. Eurofins Scientific Mycoplasma Detection Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Eurofins Scientific Mycoplasma Detection Service Product Portfolio Table 90. Eurofins Scientific Recent Development Table 91. Hylabs Company Information Table 92. Hylabs Business Overview Table 93. Hylabs Mycoplasma Detection Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Hylabs Mycoplasma Detection Service Product Portfolio Table 95. Hylabs Recent Development Table 96. JOINN Laboratories Company Information Table 97. JOINN Laboratories Business Overview Table 98. JOINN Laboratories Mycoplasma Detection Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. JOINN Laboratories Mycoplasma Detection Service Product Portfolio Table 100. JOINN Laboratories Recent Development Table 101. Shimadzu Diagnostics Company Information Table 102. Shimadzu Diagnostics Business Overview Table 103. Shimadzu Diagnostics Mycoplasma Detection Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Shimadzu Diagnostics Mycoplasma Detection Service Product Portfolio Table 105. Shimadzu Diagnostics Recent Development Table 106. CellSafe Company Information Table 107. CellSafe Business Overview Table 108. CellSafe Mycoplasma Detection Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. CellSafe Mycoplasma Detection Service Product Portfolio Table 110. CellSafe Recent Development Table 111. FullHope Biomedical Company Information Table 112. FullHope Biomedical Business Overview Table 113. FullHope Biomedical Mycoplasma Detection Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. FullHope Biomedical Mycoplasma Detection Service Product Portfolio Table 115. FullHope Biomedical Recent Development Table 116. Syngene International Company Information Table 117. Syngene International Business Overview Table 118. Syngene International Mycoplasma Detection Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Syngene International Mycoplasma Detection Service Product Portfolio Table 120. Syngene International Recent Development Table 121. Beyotime Company Information Table 122. Beyotime Business Overview Table 123. Beyotime Mycoplasma Detection Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Beyotime Mycoplasma Detection Service Product Portfolio Table 125. Beyotime Recent Development Table 126. CTI Cert Company Information Table 127. CTI Cert Business Overview Table 128. CTI Cert Mycoplasma Detection Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. CTI Cert Mycoplasma Detection Service Product Portfolio Table 130. CTI Cert Recent Development Table 131. Shenke Bio Company Information Table 132. Shenke Bio Business Overview Table 133. Shenke Bio Mycoplasma Detection Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Shenke Bio Mycoplasma Detection Service Product Portfolio Table 135. Shenke Bio Recent Development Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Mycoplasma Detection Service Product Image Figure 2. Global Mycoplasma Detection Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mycoplasma Detection Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Mycoplasma Detection Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Culture-based Mycoplasma Detection Image Figure 8. PCR/qPCR Mycoplasma Detection Image Figure 9. Others Image Figure 10. Global Mycoplasma Detection Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Mycoplasma Detection Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Mycoplasma Detection Service Sales Value Share by Type (2021-2032) Figure 13. Biopharmaceutical Companies Image Figure 14. Contract Research/Manufacturing Organizations (CROs/CMOs) Image Figure 15. Universities and Research Institutions Image Figure 16. Others Image Figure 17. Global Mycoplasma Detection Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Mycoplasma Detection Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Mycoplasma Detection Service Sales Value Share by Application (2021-2032) Figure 20. Global Mycoplasma Detection Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Mycoplasma Detection Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Mycoplasma Detection Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Mycoplasma Detection Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Mycoplasma Detection Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Mycoplasma Detection Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Mycoplasma Detection Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Mycoplasma Detection Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Mycoplasma Detection Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Mycoplasma Detection Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Mycoplasma Detection Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Mycoplasma Detection Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Mycoplasma Detection Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Culture-based Mycoplasma Detection
  • PCR/qPCR Mycoplasma Detection
  • Others
Applications
  • Biopharmaceutical Companies
  • Contract Research/Manufacturing Organizations (CROs/CMOs)
  • Universities and Research Institutions
  • Others
Companies covered
  • Charles River Laboratories International
  • Thermo Fisher Scientific
  • SGS
  • Bionique Testing Laboratories
  • WuXi AppTec
  • Labcorp
  • IDEXX BioAnalytics
  • WiCell
  • Creative Biogene
  • Eurofins Scientific
  • Hylabs
  • JOINN Laboratories
  • Shimadzu Diagnostics
  • CellSafe
  • FullHope Biomedical
  • Syngene International
  • Beyotime
  • CTI Cert
  • Shenke Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mycoplasma Detection Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mycoplasma Detection Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Mycoplasma Detection Service Market Dynamics
  1. 2.1 Mycoplasma Detection Service Industry Trends
  2. 2.2 Mycoplasma Detection Service Industry Drivers
  3. 2.3 Mycoplasma Detection Service Industry Opportunities and Challenges
  4. 2.4 Mycoplasma Detection Service Industry Restraints
3 Mycoplasma Detection Service Market by Company
  1. 3.1 Global Mycoplasma Detection Service Company Revenue Ranking in 2025
  2. 3.2 Global Mycoplasma Detection Service Revenue by Company (2021-2026)
  3. 3.3 Global Mycoplasma Detection Service Company Ranking (2024-2026)
  4. 3.4 Global Mycoplasma Detection Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Mycoplasma Detection Service Company Product Type and Application
  6. 3.6 Global Mycoplasma Detection Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Mycoplasma Detection Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Mycoplasma Detection Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Mycoplasma Detection Service Market by Type
  1. 4.1 Mycoplasma Detection Service Type Introduction
  2. 4.1.1 Culture-based Mycoplasma Detection
  3. 4.1.2 PCR/qPCR Mycoplasma Detection
  4. 4.1.3 Others
  5. 4.2 Global Mycoplasma Detection Service Sales Value by Type
  6. 4.2.1 Global Mycoplasma Detection Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mycoplasma Detection Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Mycoplasma Detection Service Sales Value Share by Type (2021-2032)
5 Mycoplasma Detection Service Market by Application
  1. 5.1 Mycoplasma Detection Service Application Introduction
  2. 5.1.1 Biopharmaceutical Companies
  3. 5.1.2 Contract Research/Manufacturing Organizations (CROs/CMOs)
  4. 5.1.3 Universities and Research Institutions
  5. 5.1.4 Others
  6. 5.2 Global Mycoplasma Detection Service Sales Value by Application
  7. 5.2.1 Global Mycoplasma Detection Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Mycoplasma Detection Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Mycoplasma Detection Service Sales Value Share by Application (2021-2032)
6 Mycoplasma Detection Service Regional Value Analysis
  1. 6.1 Global Mycoplasma Detection Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mycoplasma Detection Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Mycoplasma Detection Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Mycoplasma Detection Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mycoplasma Detection Service Sales Value (2021-2032)
  7. 6.3.2 North America Mycoplasma Detection Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Mycoplasma Detection Service Sales Value (2021-2032)
  10. 6.4.2 Europe Mycoplasma Detection Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Mycoplasma Detection Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Mycoplasma Detection Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Mycoplasma Detection Service Sales Value (2021-2032)
  16. 6.6.2 South America Mycoplasma Detection Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Mycoplasma Detection Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Mycoplasma Detection Service Sales Value Share by Country, 2025 VS 2032
7 Mycoplasma Detection Service Country-level Value Analysis
  1. 7.1 Global Mycoplasma Detection Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mycoplasma Detection Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Mycoplasma Detection Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Mycoplasma Detection Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Mycoplasma Detection Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Mycoplasma Detection Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Mycoplasma Detection Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River Laboratories International
  2. 8.1.1 Charles River Laboratories International Company Information
  3. 8.1.2 Charles River Laboratories International Business Overview
  4. 8.1.3 Charles River Laboratories International Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Laboratories International Mycoplasma Detection Service Product Portfolio
  6. 8.1.5 Charles River Laboratories International Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Mycoplasma Detection Service Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 SGS
  14. 8.3.1 SGS Company Information
  15. 8.3.2 SGS Business Overview
  16. 8.3.3 SGS Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SGS Mycoplasma Detection Service Product Portfolio
  18. 8.3.5 SGS Recent Developments
  19. 8.4 Bionique Testing Laboratories
  20. 8.4.1 Bionique Testing Laboratories Company Information
  21. 8.4.2 Bionique Testing Laboratories Business Overview
  22. 8.4.3 Bionique Testing Laboratories Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bionique Testing Laboratories Mycoplasma Detection Service Product Portfolio
  24. 8.4.5 Bionique Testing Laboratories Recent Developments
  25. 8.5 WuXi AppTec
  26. 8.5.1 WuXi AppTec Company Information
  27. 8.5.2 WuXi AppTec Business Overview
  28. 8.5.3 WuXi AppTec Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi AppTec Mycoplasma Detection Service Product Portfolio
  30. 8.5.5 WuXi AppTec Recent Developments
  31. 8.6 Labcorp
  32. 8.6.1 Labcorp Company Information
  33. 8.6.2 Labcorp Business Overview
  34. 8.6.3 Labcorp Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Labcorp Mycoplasma Detection Service Product Portfolio
  36. 8.6.5 Labcorp Recent Developments
  37. 8.7 IDEXX BioAnalytics
  38. 8.7.1 IDEXX BioAnalytics Company Information
  39. 8.7.2 IDEXX BioAnalytics Business Overview
  40. 8.7.3 IDEXX BioAnalytics Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 IDEXX BioAnalytics Mycoplasma Detection Service Product Portfolio
  42. 8.7.5 IDEXX BioAnalytics Recent Developments
  43. 8.8 WiCell
  44. 8.8.1 WiCell Company Information
  45. 8.8.2 WiCell Business Overview
  46. 8.8.3 WiCell Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 WiCell Mycoplasma Detection Service Product Portfolio
  48. 8.8.5 WiCell Recent Developments
  49. 8.9 Creative Biogene
  50. 8.9.1 Creative Biogene Company Information
  51. 8.9.2 Creative Biogene Business Overview
  52. 8.9.3 Creative Biogene Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Creative Biogene Mycoplasma Detection Service Product Portfolio
  54. 8.9.5 Creative Biogene Recent Developments
  55. 8.10 Eurofins Scientific
  56. 8.10.1 Eurofins Scientific Company Information
  57. 8.10.2 Eurofins Scientific Business Overview
  58. 8.10.3 Eurofins Scientific Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Eurofins Scientific Mycoplasma Detection Service Product Portfolio
  60. 8.10.5 Eurofins Scientific Recent Developments
  61. 8.11 Hylabs
  62. 8.11.1 Hylabs Company Information
  63. 8.11.2 Hylabs Business Overview
  64. 8.11.3 Hylabs Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hylabs Mycoplasma Detection Service Product Portfolio
  66. 8.11.5 Hylabs Recent Developments
  67. 8.12 JOINN Laboratories
  68. 8.12.1 JOINN Laboratories Company Information
  69. 8.12.2 JOINN Laboratories Business Overview
  70. 8.12.3 JOINN Laboratories Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 JOINN Laboratories Mycoplasma Detection Service Product Portfolio
  72. 8.12.5 JOINN Laboratories Recent Developments
  73. 8.13 Shimadzu Diagnostics
  74. 8.13.1 Shimadzu Diagnostics Company Information
  75. 8.13.2 Shimadzu Diagnostics Business Overview
  76. 8.13.3 Shimadzu Diagnostics Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shimadzu Diagnostics Mycoplasma Detection Service Product Portfolio
  78. 8.13.5 Shimadzu Diagnostics Recent Developments
  79. 8.14 CellSafe
  80. 8.14.1 CellSafe Company Information
  81. 8.14.2 CellSafe Business Overview
  82. 8.14.3 CellSafe Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CellSafe Mycoplasma Detection Service Product Portfolio
  84. 8.14.5 CellSafe Recent Developments
  85. 8.15 FullHope Biomedical
  86. 8.15.1 FullHope Biomedical Company Information
  87. 8.15.2 FullHope Biomedical Business Overview
  88. 8.15.3 FullHope Biomedical Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 FullHope Biomedical Mycoplasma Detection Service Product Portfolio
  90. 8.15.5 FullHope Biomedical Recent Developments
  91. 8.16 Syngene International
  92. 8.16.1 Syngene International Company Information
  93. 8.16.2 Syngene International Business Overview
  94. 8.16.3 Syngene International Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Syngene International Mycoplasma Detection Service Product Portfolio
  96. 8.16.5 Syngene International Recent Developments
  97. 8.17 Beyotime
  98. 8.17.1 Beyotime Company Information
  99. 8.17.2 Beyotime Business Overview
  100. 8.17.3 Beyotime Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Beyotime Mycoplasma Detection Service Product Portfolio
  102. 8.17.5 Beyotime Recent Developments
  103. 8.18 CTI Cert
  104. 8.18.1 CTI Cert Company Information
  105. 8.18.2 CTI Cert Business Overview
  106. 8.18.3 CTI Cert Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 CTI Cert Mycoplasma Detection Service Product Portfolio
  108. 8.18.5 CTI Cert Recent Developments
  109. 8.19 Shenke Bio
  110. 8.19.1 Shenke Bio Company Information
  111. 8.19.2 Shenke Bio Business Overview
  112. 8.19.3 Shenke Bio Mycoplasma Detection Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Shenke Bio Mycoplasma Detection Service Product Portfolio
  114. 8.19.5 Shenke Bio Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst